Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Swiss based Solmic AG has a strong IP portfolio including unique formulation technology for the production of stable micelles containing water insoluble compounds such as CBD. Solmic AG's unique micelle production technology has been shown to greatly enhance the bioavailability of fat soluble ingredients by as much as 15 times.

List your booth number for exhibitions, ask us